381 related articles for article (PubMed ID: 22369740)
1. Transforming growth factor-β1 induced epithelial-mesenchymal transition in hepatic fibrosis.
Bi WR; Yang CQ; Shi Q
Hepatogastroenterology; 2012 Sep; 59(118):1960-3. PubMed ID: 22369740
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic regulation of transmembrane 4 L6 family member 5 attenuates fibrotic phenotypes in CCl(4) -treated mice.
Kang M; Jeong SJ; Park SY; Lee HJ; Kim HJ; Park KH; Ye SK; Kim SH; Lee JW
FEBS J; 2012 Feb; 279(4):625-35. PubMed ID: 22177033
[TBL] [Abstract][Full Text] [Related]
3. RAR-Related Orphan Receptor Gamma (ROR-γ) Mediates Epithelial-Mesenchymal Transition Of Hepatocytes During Hepatic Fibrosis.
Kim SM; Choi JE; Hur W; Kim JH; Hong SW; Lee EB; Lee JH; Li TZ; Sung PS; Yoon SK
J Cell Biochem; 2017 Aug; 118(8):2026-2036. PubMed ID: 27791279
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes.
Kaimori A; Potter JJ; Choti M; Ding Z; Mezey E; Koteish AA
Hepatology; 2010 Sep; 52(3):1033-45. PubMed ID: 20564330
[TBL] [Abstract][Full Text] [Related]
5. Apamin inhibits hepatic fibrosis through suppression of transforming growth factor β1-induced hepatocyte epithelial-mesenchymal transition.
Lee WR; Kim KH; An HJ; Kim JY; Lee SJ; Han SM; Pak SC; Park KK
Biochem Biophys Res Commun; 2014 Jul; 450(1):195-201. PubMed ID: 24878534
[TBL] [Abstract][Full Text] [Related]
6. The ratio of transforming growth factor-β1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis.
Bi WR; Xu GT; Lv LX; Yang CQ
Genet Mol Res; 2014 Feb; 13(1):1005-14. PubMed ID: 24634122
[TBL] [Abstract][Full Text] [Related]
7. Glutamine inhibits CCl4 induced liver fibrosis in mice and TGF-β1 mediated epithelial-mesenchymal transition in mouse hepatocytes.
Shrestha N; Chand L; Han MK; Lee SO; Kim CY; Jeong YJ
Food Chem Toxicol; 2016 Jul; 93():129-37. PubMed ID: 27137983
[TBL] [Abstract][Full Text] [Related]
8. Cytoskeletal re-arrangement in TGF-β1-induced alveolar epithelial-mesenchymal transition studied by atomic force microscopy and high-content analysis.
Buckley ST; Medina C; Davies AM; Ehrhardt C
Nanomedicine; 2012 Apr; 8(3):355-64. PubMed ID: 21756862
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-alpha enhances both epithelial-mesenchymal transition and cell contraction induced in A549 human alveolar epithelial cells by transforming growth factor-beta1.
Yamauchi Y; Kohyama T; Takizawa H; Kamitani S; Desaki M; Takami K; Kawasaki S; Kato J; Nagase T
Exp Lung Res; 2010 Feb; 36(1):12-24. PubMed ID: 20128678
[TBL] [Abstract][Full Text] [Related]
10. [The role of TGFbeta1 and IL-13 in cellular signal transduction of hepatic fibrosis of schistosomiasis].
Li J; Wang W; Shen JL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Aug; 27(4):357-60. PubMed ID: 20066997
[TBL] [Abstract][Full Text] [Related]
11. Pterostilbene prevents hepatocyte epithelial-mesenchymal transition in fructose-induced liver fibrosis through suppressing miR-34a/Sirt1/p53 and TGF-β1/Smads signalling.
Song L; Chen TY; Zhao XJ; Xu Q; Jiao RQ; Li JM; Kong LD
Br J Pharmacol; 2019 Jun; 176(11):1619-1634. PubMed ID: 30632134
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of early liver fibrosis by herbal compound "Diwu Yanggan" through modulating the balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition.
Shen X; Cheng S; Peng Y; Song H; Li H
BMC Complement Altern Med; 2014 Oct; 14():418. PubMed ID: 25345787
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory cytokines augments TGF-beta1-induced epithelial-mesenchymal transition in A549 cells by up-regulating TbetaR-I.
Liu X
Cell Motil Cytoskeleton; 2008 Dec; 65(12):935-44. PubMed ID: 18792103
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.
Dooley S; Hamzavi J; Ciuclan L; Godoy P; Ilkavets I; Ehnert S; Ueberham E; Gebhardt R; Kanzler S; Geier A; Breitkopf K; Weng H; Mertens PR
Gastroenterology; 2008 Aug; 135(2):642-59. PubMed ID: 18602923
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
17. Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells.
Mariasegaram M; Tesch GH; Verhardt S; Hurst L; Lan HY; Nikolic-Paterson DJ
Biochem Biophys Res Commun; 2010 Mar; 393(4):855-9. PubMed ID: 20171171
[TBL] [Abstract][Full Text] [Related]
18. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck.
Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X
Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366
[TBL] [Abstract][Full Text] [Related]
19. MiR-146a attenuates liver fibrosis by inhibiting transforming growth factor-β1 mediated epithelial-mesenchymal transition in hepatocytes.
Zou Y; Li S; Li Z; Song D; Zhang S; Yao Q
Cell Signal; 2019 Jun; 58():1-8. PubMed ID: 30711634
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
